AKT2 Gene Diabetes Mellitus, Noninsulin-Dependent, Genetic Test in UAE | AED 2800 | 2026 DHA Guidelines

تحليل جين AKT2 لمرض السكري غير المعتمد على الأنسولين في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Executive Summary (ملخص تنفيذي)

يضمن هذا الفحص الجيني المتطور دقة تصل إلى 99.9% باستخدام تقنية التسلسل الجيني من الجيل التالي، مع خدمة سحب منزلي معتمدة واستشارة طبية بعد النتائج، وفقاً لأحدث معايير هيئة الصحة بدبي.

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited processing (Cert: INT/EGQ/2509DA/3139), compliant with Federal Decree-Law No. 41 of 2024 (Art. 87).
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection (8 AM – 11 PM) and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post–Test Clinical Guidance in result interpretation with a DHA-licensed genetic counselor.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

Overview

The AKT2 Gene NGS Test screens for pathogenic variants in the AKT2 gene associated with monogenic noninsulin-dependent diabetes, enabling precise diagnosis and personalized management. يكتشف تحليل جين AKT2 الطفرات المسببة لمرض السكري غير المعتمد على الأنسولين، مما يساعد في التشخيص الدقيق.

Feature	Our Test	Closest Alternative (Whole Exome)
Methodology	Targeted NGS (high-depth AKT2 gene sequencing)	Whole Exome Sequencing (lower coverage per gene)
Turnaround Time	3 – 4 Weeks	6 – 8 Weeks
Diagnostic Yield	>99.9% sensitivity for AKT2 variants	Variable; may miss deep intronic variants
Cost	AED 2800	Typically AED 5000+

Physician Insight & Safety Protocol

“As a clinician, I understand that receiving genetic information can be overwhelming. Please remember that a positive result indicates predisposition, not a definitive diagnosis; clinical correlation with your endocrinologist is essential to tailor your management plan. Our team, under my supervision, is here to guide you through every step.”

— Dr. PRABHAKAR REDDY, DHA License: 61713011

⚠️ Medication Warning: Do not discontinue or adjust any prescribed diabetes medications without consulting your treating physician.

Safety & Exclusion Criteria

Exclusions: Individuals under 18 without legal guardian consent (CDS Law 2026), severe hemophilia or active anticoagulation (risk of excessive bleeding), inability to provide informed consent.
ER Red Flags: If you experience signs of severe hypoglycemia (confusion, seizures, loss of consciousness) or diabetic ketoacidosis (nausea, vomiting, abdominal pain, fruity breath), seek immediate emergency care.

Pre‑Test Information

A genetic counseling session is required before sample collection to draw a pedigree chart of family members affected with noninsulin‑dependent diabetes. This step ensures accurate interpretation of your results and is fully supported by our DHA‑licensed genetic counselors.

Sample required: Blood (venous draw) collected by our certified phlebotomist. No fasting is necessary unless otherwise advised.

Patient FAQ & Clinical Guidance

Q1: What is the AKT2 gene and its role in noninsulin‑dependent diabetes? (ما هو جين AKT2 ودوره في مرض السكري غير المعتمد على الأنسولين؟)

Snippet: This test screens for pathogenic variants in the AKT2 gene, which encodes a critical insulin signaling protein, identifying monogenic diabetes that often mimics type 2 diabetes. The result can distinguish whether your diabetes has a strong genetic cause requiring tailored therapy.

يكشف الاختبار عن طفرات جين AKT2 المسؤول عن إشارات الأنسولين، مما يساعد على تشخيص أنواع السكري أحادية الجين التي قد تُخطئ مع السكري من النوع الثاني.

Q2: Who should consider taking this genetic? (من هم المرشحون لإجراء هذا التحليل الجيني؟)

Snippet: Individuals with a strong family history of early‑onset diabetes, unexplained non‑autoimmune diabetes, or syndromic features suggestive of monogenic diabetes should consider this targeted genetic analysis. It is particularly useful for patients diagnosed before age 40 who do not fit typical type 2 profiles.

يُنصح بهذا التحليل للأشخاص الذين لديهم تاريخ عائلي قوي لمرض السكري في سن مبكرة، أو وجود علامات سريرية غير مفسرة، خاصة للمصابين قبل سن الأربعين.

Q3: How long does it take to receive results and how are they interpreted? (كم يستغرق الحصول على النتائج وكيف تُفسر؟)

Snippet: Results are typically delivered within 3 to 4 weeks, accompanied by a comprehensive report interpreted by a certified genetic counselor and your referring specialist. The report includes variant classification according to ACMG guidelines and personalized management recommendations.

تصدر النتائج خلال 3 إلى 4 أسابيع مع تقرير مفصل يفسره مستشار وراثي معتمد والطبيب المختص، ويتضمن توصيات علاجية مخصصة.

DHA Facility License: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | Testing complies with Federal Decree‑Law No. 41 of 2024 (Art. 87), UAE CDS Law 2026 (Minors) and UAE PDPL.

Loinc Code: 51969-4 (loinc.org/51969-4/) | ICD‑10‑CM: E11.9, Z13.1, Z15.81

دعم ثنائي اللغة متاح